These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 6137606)

  • 1. DDAVP in haemophilia and von Willebrand's disease.
    Lancet; 1983 Oct; 2(8353):774-5. PubMed ID: 6137606
    [No Abstract]   [Full Text] [Related]  

  • 2. New ways to boost factor VIII in hemophilia: DDAVP for mild hemophilia A, von Willebrand's.
    Marwick C
    JAMA; 1983 Jun; 249(24):3278-9. PubMed ID: 6406692
    [No Abstract]   [Full Text] [Related]  

  • 3. [Desamino-8-D-arginine vasopressin nose drops in the treatment of mild hemophilia A and von Willebrand's disease].
    Streit A; Furlan M; Beck EA
    Schweiz Med Wochenschr; 1984 Oct; 114(40):1389-91. PubMed ID: 6333722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DDAVP: alternative therapy in moderate pathology of Factor VIII/von Willebrand].
    Vicente V; Alberca I; Moraleda JM; López Borrasca A
    Sangre (Barc); 1983; 28(4):531-2. PubMed ID: 6606856
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hemophilia A and von Willebrand's disease with 1-deamino-8-D-arginine vasopressin (DDAVP). Hemophilia and DDAVP].
    Ingerslev J; Christiansen SE; Kristensen T; Wallevik K; Bernvil SS
    Ugeskr Laeger; 1985 Nov; 147(45):3592-4. PubMed ID: 3907076
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patients.
    Mariana G; Ciavarella N; Mazzucconi MG; Antoncecchi S; Solinas S; Ranieri P; Pettini P; Agrestini F; Mandelli F
    Clin Lab Haematol; 1984; 6(3):229-38. PubMed ID: 6440729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Deamino-8-D-arginine-vasopressin--an alternative in the management of mild haemophilia A and von Willebrand's disease.
    Niessner H; Korninger C
    Wien Klin Wochenschr; 1983 Nov; 95(21):753-7. PubMed ID: 6424339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease.
    Takahashi H
    Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):357-65. PubMed ID: 6791293
    [No Abstract]   [Full Text] [Related]  

  • 9. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
    Ruggeri ZM; Mannucci PM; Lombardi R; Federici AB; Zimmerman TS
    Blood; 1982 Jun; 59(6):1272-8. PubMed ID: 6805532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
    Fukui H; Takase T
    Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720
    [No Abstract]   [Full Text] [Related]  

  • 11. [DDAVP: alternative to replacement treatment in mild haemophilia A and von Willebrand-Jürgens syndrome (author's transl)].
    Theiss W; Sauer E
    Dtsch Med Wochenschr; 1977 Dec; 102(48):1769-72. PubMed ID: 303563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of blood coagulation disorders with the vasopressin derivative DDAVP (Minirin)].
    Köhler M; Hellstern P; Vief B; Wenzel E
    ZFA (Stuttgart); 1981 May; 57(15):1132-5. PubMed ID: 6973250
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of hemophilia A and von Willebrand's disease patients with an intranasal dripping of DDAVP.
    Kobayashi I
    Thromb Res; 1979; 16(5-6):775-9. PubMed ID: 316584
    [No Abstract]   [Full Text] [Related]  

  • 14. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
    Warrier AI; Lusher JM
    J Pediatr; 1983 Feb; 102(2):228-33. PubMed ID: 6401806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of the chromogenic assay of factor VIII in haemophilia A, and different variants of von Willebrand's disease.
    Lethagen S; Ostergaard H; Nilsson IM
    Scand J Haematol; 1986 Nov; 37(5):448-53. PubMed ID: 3101169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with arginine vasopressin (DDAVP) in von Willebrand's disease and mild haemophilia.
    Ockelford PA; Menon NC; Berry EW
    N Z Med J; 1980 Nov; 92(672):375-8. PubMed ID: 6970907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with deamino-8-D-AGR-Vasopressin (DDAVP) in patients with Factor VIII deficiency.
    Sweeney JD; Crosby P; McCann SR; Temperley IJ
    Ir J Med Sci; 1981 Aug; 150(8):236-9. PubMed ID: 6974718
    [No Abstract]   [Full Text] [Related]  

  • 18. [Response to DDAVP in von Willebrand disease type II C].
    Batllé Fonrodona J; López Fernández MF; Martín González R; Fernández Villamor A; López Borrasca A; Lasierra Cirujeda J
    Sangre (Barc); 1985; 30(2):181-4. PubMed ID: 3925573
    [No Abstract]   [Full Text] [Related]  

  • 19. DDAVP in von Willebrand's disease: repeated administration and the behaviour of the bleeding time.
    Theiss W; Schmidt G
    Thromb Res; 1978 Dec; 13(6):1119-23. PubMed ID: 311959
    [No Abstract]   [Full Text] [Related]  

  • 20. Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin.
    de la Fuente B; Kasper CK; Rickles FR; Hoyer LW
    Ann Intern Med; 1985 Jul; 103(1):6-14. PubMed ID: 3923887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.